01 · Act or remain with the status quo
Budget, timing and not a priority describe where a deal ended. A No-Decision Diagnosis reconstructs why the purchase never gathered enough momentum to happen.
Definition
A No-Decision Diagnosis is a customer research study that reconstructs why qualified B2B buyers understood a product and still did not reach a buying decision. It interviews recent, qualified non-buyers to recover the timeline, the triggering events, the buying-group dynamics and the alternative path taken. It explains the no-decision rate, which counts stalled deals without saying what stalled them.
You may need more of the qualified pipeline you already have to become an actual buying decision.
Economics
Not every stalled deal was winnable. This models the first-year revenue attached to the ones that never reached a yes or a no.
Qualified opportunities × no-decision rate × expected win rate × average new-customer ARR
Over one consistent measurement period.
This is value exposed, not guaranteed recoverable revenue. Some of these buyers were never going to move, and a study that finds that is still a useful result.
Break-even framing in percentage points of movement. Method does not change the size of that movement. It changes how much of the explanation you can trust, and therefore which decisions you can defend making from it. It shows the share of exposed value a study would need to help recover before it has paid for itself. It is not a projected return, and pricing shown is a floor and a typical range, scoped per engagement. See how the three methods differ.
What the study resolves
Business implications
Recognize strong struggling moments, meaningful triggers and false opportunities earlier.
Address the progress buyers seek and the risks preventing internal commitment.
Improve discovery, buying-group involvement and the timing and type of proof.
Engagement outline
Review funnel definitions, loss data and current explanations.
Select recent, qualified non-buyers with meaningful exposure to the decision.
Recover the timeline, forces, buying-group dynamics and alternative path.
Deliver patterns, exceptions, commercial implications and predictions to test in pipeline data.
Synthetic, AI-moderated and 1:1 expert execution options are compared on the methods page.
Fit
Best suited to sales-led Seed to Series B B2B SaaS companies experiencing:
Common questions
Because understanding a product is not the same as developing enough urgency to change. A buyer can grasp the value, agree it would help, and still find that the current way of working is tolerable enough to keep. Stalls usually trace back to a struggling moment that was never strong enough, or a buying group where momentum weakened before commitment formed.
It can be either, and the rate alone cannot tell you which. If buyers never had a real struggling moment, it is a demand and qualification problem. If they did and the purchase still lost momentum internally, it is a positioning or proof problem. A No-Decision Diagnosis separates the two by reconstructing what actually happened.
Win/loss analysis studies deals that reached a decision, which means it looks at buyers who chose you or chose a competitor. A No-Decision Diagnosis studies the deals that reached no decision at all. Those buyers are usually excluded from win/loss programs entirely, which is why the largest category of lost pipeline often goes unexplained.
When you cannot reach recent qualified non-buyers who remember the decision, or when the number is not yet commercially important enough to act on. Research is worth running when a metric matters, the team lacks confidence in its explanation, the behavior is potentially changeable, and buyers can still reconstruct what happened.
Start with one stalled decision
Bring your no-decision rate, current loss reasons and one explanation your team is no longer confident in.